Get started

X-indicator

Stock Analysis: #SPANDANA – Rising with Unusual StrengthHello, Traders! 👋 After a sharp decline of 65% from its highs, #SPANDANA is showing strong signs of recovery: 📈 Technical Highlights: 🔹 Yearly and highest-ever volume recorded for consecutive days—indicating something significant may be unfolding. 🔹 The stock has gained 17%+ for the last two days, signaling momentum. 🔹 It popped up on my weekly scanner, and I’m keeping a close eye on it. 💡 Previous Performance: The last entry triggered by my ILTF indicator delivered a massive 130% gain. 💡 Current Plan: I’m tracking this closely until the weekly close to assess the setup and identify a better entry point if the momentum sustains. ⚠️ Disclaimer: 🔹 I am not a SEBI-registered advisor. 🔹 This analysis reflects my personal views and is not a recommendation to buy or sell. 🔹 Shared purely for learning purposes—please do your own research or consult a professional before making any decisions. Let’s see how this unfolds—could it be another big mover? 🚀 #TradingView #StockAnalysis #MomentumStocks #SPANDANA #SwingTrading
NSE:SPANDANALong
by Inwardlocus
OIL bullish for short term upside to 550Hello Everyone, Have spotted a bullish pattern on the chart that can take the prices to 510-550 in the short while. Points to note: > Out of all, Oil sector is showing some strength. > OIL has seen recovery for the current support levels multiple times in the past. > Trading above 100EMA with good volumes. > Hammer spotted Important leves: Support: 464 Resistence: 450 Entry Levels: 485-490 Exit Levels: 464 or trail with EMA 100 once it breaches 500 levels. Risk to Reward: Optimal Entry 485 – Target 550 = Almost 3x Reward to Risk
NSE:OILLong
by madhubansal
4
Bharati Airtel Ltd view for Intraday 8th Jan #BHARTIARTL Bharati Airtel Ltd view for Intraday 8th Jan #BHARTIARTL Resistance 1600 Watching above 1603 for upside movement... Support area 1570 Below 1585 ignoring upside momentum for intraday Support 1570 Watching below 1585 or downside movement... Resistance area 1600 Above 1600 ignoring downside move for intraday Charts for Educational purposes only. Please follow strict stop loss and risk reward if you follow the level. Thanks,
NSE:BHARTIARTLLong
by EmpireCrown
Stock Analysis: #PARAS – Early Potential ReversalHello, Traders! 👋 Let’s talk about #PARAS, a defence sector stock that is showing strong signs of a potential upmove. Here's the breakdown: 📈 Technical Overview: 🔹 The stock has posted its highest quarterly volume for consecutive days, indicating strong accumulation. 🔹 It is trading near a multi-week breakout level on the weekly chart and is well above the last two weeks' highs. 🔹 Momentum in the defence sector aligns well with the stock's setup, enhancing its potential. 💡 My View: My ILTF indicator signaled an entry earlier, but broader market conditions weren’t favorable then, leading to an exit signal later. Now, it looks like #PARAS might turn positive again. Tracking closely for confirmation. ⚠️ Disclaimer: 🔹 I am not a SEBI-registered advisor. 🔹 This analysis reflects my personal views and is not a recommendation to buy or sell. 🔹 Shared for learning purposes only—please do your own research or consult a professional. Are you watching the defence sector momentum? Let’s discuss #PARAS! 🚀 #TradingView #StockAnalysis #DefenceStocks #MomentumTrading #PARAS
NSE:PARAS
by Inwardlocus
Morepen Lab Near Key Support – Big Move Ahead?Morepen Laboratories (NSE: MOREPENLAB) - A Critical Technical Setup In-Depth Chart Analysis 1. Descending Trendline Resistance: • The stock is moving within a descending triangle pattern, with a clear downward trendline acting as resistance since the peak around ₹120. • Currently, the stock is approaching this trendline near ₹80. A breakout above this level, supported by strong volume, could trigger bullish momentum. 2. Key Moving Averages: • 200-Day EMA (Exponential Moving Average): The 200-day EMA is positioned at ₹69.66, which serves as a critical long-term support. The stock has tested this level multiple times, indicating its importance. • The price is hovering slightly above the EMA, suggesting the stock is at a decisive point for trend confirmation. 3. Support Levels: • ₹69.66: Immediate support lies here, aligning with the 200-day EMA. If this level holds, the stock could see a bounce toward higher resistance levels. • ₹65.00 and ₹55.00: If the stock fails to hold ₹69.66, it could slide to ₹65.00, a psychological support, and then to ₹55.00, which marks a previous consolidation zone. 4. Resistance Levels: • ₹80.00: The descending trendline converges with this resistance. A breakout above ₹80.00 could open the path to ₹95.00. • ₹95.00: A crucial horizontal resistance zone. Beyond this, ₹115.00 could be the next major target. 5. Volume Profile: • Recent volume spikes near support levels suggest accumulation by long-term investors. • Watch for increasing volume during any breakout above ₹80.00, which would confirm strong buying interest. 6. Bollinger Bands: • The price is trading near the lower Bollinger Band, indicating oversold conditions. • A rebound toward the middle or upper band could align with a breakout above the ₹80.00 resistance. 7. RSI (Relative Strength Index): • The RSI is nearing the oversold zone, typically a precursor to a potential reversal. 8. Symmetrical Triangle Formation: • The stock’s current price action within a triangle pattern indicates consolidation. A breakout above the upper trendline or a breakdown below the lower support will dictate the next directional move. Possible Scenarios: Bullish Scenario: • A breakout above ₹80.00 with high volume can propel the stock to test ₹95.00 in the short term. • Sustaining above ₹95.00 could lead to a rally toward ₹115.00, marking a significant reversal of the bearish trend. Bearish Scenario: • A breakdown below ₹69.66 would indicate the continuation of the descending triangle, leading to lower levels like ₹65.00 and ₹55.00. • Increased selling pressure or market weakness could exacerbate the downside. About Morepen Laboratories Company Overview: Morepen Laboratories is a pharmaceutical and healthcare company specializing in Active Pharmaceutical Ingredients (APIs), formulations, and diagnostics. With a strong domestic presence and growing exports, the company’s key products include Loratadine (an anti-allergic API) and well-known OTC brands like Burnol and Dr. Morepen. Financial Highlights: • Revenue: The company has demonstrated consistent revenue growth, driven by exports and rising healthcare demand in India. • Margins: Operating margins are moderate, with scope for improvement as exports scale up. • Debt Levels: A low debt-to-equity ratio reflects strong financial stability. • Cash Flow: Positive operating cash flow highlights effective financial management. Growth Drivers: 1. Increasing demand for APIs globally, especially in regulated markets. 2. Expansion into diagnostics and OTC segments, with a focus on high-margin products. 3. Government incentives under the “Make in India” initiative for the pharmaceutical sector. 4. Investment in R&D to create niche formulations and increase market penetration. Conclusion: The stock is at a pivotal technical and fundamental point. A decisive breakout above ₹80.00 could signal the start of a bullish trend, while a breakdown below ₹69.66 might lead to further downside. Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Please conduct your own research and consult a certified financial advisor before making investment decisions.
NSE:MOREPENLAB
by Veersoni108